Cecenu

Cecenu may be available in the countries listed below.

Ingredient matches for Cecenu

Lomustine

Lomustine is reported as an ingredient of Cecenu in the following countries:

• Germany

International Drug Name Search

Infeflox

Infeflox may be available in the countries listed below.

Ingredient matches for Infeflox

Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Infeflox in the following countries:

• Greece

International Drug Name Search

Deconamine Liquid

Pronunciation: klor-fen-IHR-ah-meen/sue-do-eh-FED-rin
Generic Name: Chlorpheniramine/Pseudoephedrine
Brand Name: Examples include Deconamine and PediaCare Cold/Allergy

Deconamine Liquid is used for:

Relieving symptoms of sinus congestion, sinus pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

Deconamine Liquid is an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, relieving congestion and pressure.

Do NOT use Deconamine Liquid if:

• you are allergic to any ingredient in Deconamine Liquid


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems


• you take sodium oxybate (GHB) or if you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Deconamine Liquid:

Some medical conditions may interact with Deconamine Liquid. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of asthma, lung problems (eg, emphysema), adrenal gland problems (eg, adrenal gland tumor), heart problems, high blood pressure, diabetes, heart blood vessel problems, stroke, glaucoma, a blockage of your stomach or intestines, ulcers, a blockage of your bladder, trouble urinating, an enlarged prostate, seizures, or an overactive thyroid

Some MEDICINES MAY INTERACT with Deconamine Liquid. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAOIs (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Deconamine Liquid's side effects


• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Bromocriptine or hydantoins (eg, phenytoin) because the risk of their side effects may be increased by Deconamine Liquid


• Guanethidine, guanadrel, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Deconamine Liquid

This may not be a complete list of all interactions that may occur. Ask your health care provider if Deconamine Liquid may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Deconamine Liquid:

Use Deconamine Liquid as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Deconamine Liquid by mouth with or without food.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• If you miss a dose of Deconamine Liquid, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Deconamine Liquid.

Important safety information:

• Deconamine Liquid may cause dizziness, drowsiness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Deconamine Liquid with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not take diet or appetite control medicines while you are taking Deconamine Liquid without checking with you doctor.


• Deconamine Liquid has pseudoephedrine in it. Before you start any new medicine, check the label to see if it has pseudoephedrine in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• If your symptoms do not get better within 5 to 7 days or if they get worse, check with your doctor.


• Deconamine Liquid may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Deconamine Liquid. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Deconamine Liquid may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Deconamine Liquid for a few days before the tests.


• Tell your doctor or dentist that you take Deconamine Liquid before you receive any medical or dental care, emergency care, or surgery.


• Use Deconamine Liquid with caution in the ELDERLY; they may be more sensitive to its effects.


• Caution is advised when using Deconamine Liquid in CHILDREN; they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Deconamine Liquid while you are pregnant. It is not known if Deconamine Liquid is found in breast milk. Do not breast-feed while taking Deconamine Liquid.

Possible side effects of Deconamine Liquid:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Deconamine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of Deconamine Liquid:

Store Deconamine Liquid at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Deconamine Liquid out of the reach of children and away from pets.

General information:

• If you have any questions about Deconamine Liquid, please talk with your doctor, pharmacist, or other health care provider.


• Deconamine Liquid is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Deconamine Liquid. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Deconamine resources

• Deconamine Side Effects (in more detail)
• Deconamine Use in Pregnancy & Breastfeeding
• Deconamine Drug Interactions
• Deconamine Support Group
• 2 Reviews for Deconamine - Add your own review/rating

Compare Deconamine with other medications

• Hay Fever
• Sinusitis

Betaine hydrochloride

Betaine hydrochloride may be available in the countries listed below.

Ingredient matches for Betaine hydrochloride

Betaine

Betaine hydrochloride (USAN) is known as Betaine in the US.

International Drug Name Search

Glossary

USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tricolocion

Tricolocion may be available in the countries listed below.

Ingredient matches for Tricolocion

Minoxidil

Minoxidil is reported as an ingredient of Tricolocion in the following countries:

• Argentina

International Drug Name Search

Cebutral

Cebutral may be available in the countries listed below.

Ingredient matches for Cebutral

Acebutolol

Acebutolol is reported as an ingredient of Cebutral in the following countries:

• Tunisia

International Drug Name Search

Pamidrom

Pamidrom may be available in the countries listed below.

Ingredient matches for Pamidrom

Pamidronic Acid

Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Pamidrom in the following countries:

• Brazil

International Drug Name Search

Rosiglitazone

In the US, Rosiglitazone (rosiglitazone systemic) is a member of the drug class thiazolidinediones and is used to treat Diabetes - Type 2 and Nonalcoholic Fatty Liver Disease.

US matches:

• Rosiglitazone


• Rosiglitazone/Metformin


• Rosiglitazone and glimepiride


• Rosiglitazone and metformin


• Rosiglitazone Maleate


• Rosiglitazone Maleate/Glimepiride


• Rosiglitazone Maleate/Metformin Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BG02

CAS registry number (Chemical Abstracts Service)

0122320-73-4

Chemical Formula

C18-H19-N3-O3-S

Molecular Weight

357

Therapeutic Category

Oral antidiabetic agent, insulin sensitizer, thiazolidinedione (glitazone)

Chemical Names

(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione (WHO)

(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion (IUPAC)

Foreign Names

• Rosiglitazonum (Latin)
• Rosiglitazon (German)
• Rosiglitazone (French)
• Rosiglitazona (Spanish)

Generic Names

• Rosiglitazone (OS: DCF, BAN)
• Rosiglitazone Maleate (OS: USAN)
• BRL 49653 C (IS: SmithKlineBeec)

Brand Names

• Avaglim (Rosiglitazone and Glimepiride)
  Glaxo SmithKline, Spain; GlaxoSmithKline, Denmark; GlaxoSmithKline, Slovenia



• Avandaglim (Rosiglitazone and Glimepiride)
  GlaxoSmithKline, Russian Federation



• Avandamet (Rosiglitazone and Metformin)
  Glaxo SmithKline, Spain; GlaxoSmithKline, Denmark; GlaxoSmithKline, Peru; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, United States; SmithKline Beecham, Slovenia



• Avandia
  GlaxoSmithKline, Portugal; Smithkline Beechamn, Bulgaria



• Diaglinex
  Drugtech, Peru



• Gaudil
  Craveri, Argentina



• Grexa Plus (Rosiglitazone and Glimepiride)
  Farmindustria, Peru



• Roglit
  Gedeon Richter, Georgia; Gedeon Richter, Russian Federation



• Romerol
  Drug International, Bangladesh



• Rosit
  Delta, Bangladesh



• Roziglitazon Pliva
  Pliva, Croatia (Hrvatska)



• Sensulin
  Square, Bangladesh



• Weigeluo
  Sunve, China



• Avaglim (Rosiglitazone and Glimepiride)
  GlaxoSmithKline, Germany; GlaxoSmithKline, Hungary; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden; SmithKline Beecham, Austria



• Avandamet (Rosiglitazone and Metformin)
  Glaxo Wellcome, Bulgaria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; GlaxoSmithKline, Thailand; SB Pharmco, United States; SmithKline Beecham, Austria



• Avandaryl (Rosiglitazone and Glimepiride)
  GlaxoSmithKline, Bahrain; GlaxoSmithKline, Canada; GlaxoSmithKline, Indonesia; GlaxoSmithKline, United States



• Avandia
  Glaxo SmithKline, Spain; GlaxoSmithKline, Antigua & Barbuda; GlaxoSmithKline, Netherlands Antilles; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Aruba; GlaxoSmithKline, Bosnia & Herzegowina; GlaxoSmithKline, Barbados; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Bermuda; GlaxoSmithKline, Brazil; GlaxoSmithKline, Bahamas; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Dominican Republic; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Grenada; GlaxoSmithKline, Greece; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Guyana; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Honduras; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Jamaica; GlaxoSmithKline, Cayman Islands; GlaxoSmithKline, Saint Lucia; GlaxoSmithKline, Sri Lanka; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Myanmar; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Nicaragua; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Panama; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Thailand; GlaxoSmithKline, Turkey; GlaxoSmithKline, Trinidad & Tobago; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Vietnam; GlaxoSmithKline, South Africa; SmithKline Beecham, Austria; SmithKline Beecham, Slovenia



• Diaben
  Elea, Argentina



• Dorosi
  Domesco, Vietnam



• Glimide
  Beta, Argentina



• Gliximina
  Denver, Argentina



• Gludex
  Montpellier, Argentina



• Hasandia
  Hasan, Vietnam



• Nor glitazon
  Teramed, El Salvador



• Rezult
  Sun, India; Sun, Myanmar



• Rezult-M (Rosiglitazone and Metformin)
  Sun, India



• Rosenda
  Biofarma, Turkey



• Rosicon
  Glenmark, India; Glenmark, Sri Lanka; Glenmark, Myanmar



• Rosicon-MF (Rosiglitazone and Metformin)
  Glenmark, Myanmar



• Rosiglit
  Lazar, Argentina



• Rosiglitazona Richet
  Richet, Argentina



• Rositaz
  Abdi Ibrahim, Turkey



• Rosvel
  Sanovel, Turkey

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Dryclox

Dryclox may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dryclox

Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Dryclox in the following countries:

• Australia


• New Zealand

Cloxacillin

Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Dryclox in the following countries:

• Australia


• New Zealand

International Drug Name Search

Ribomicin

Ribomicin may be available in the countries listed below.

Ingredient matches for Ribomicin

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Ribomicin in the following countries:

• Italy

International Drug Name Search

Clenbuterolo

Clenbuterolo may be available in the countries listed below.

Ingredient matches for Clenbuterolo

Clenbuterol

Clenbuterolo (DCIT) is also known as Clenbuterol (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Ferimax

Ferimax may be available in the countries listed below.

Ingredient matches for Ferimax

Iron Polymaltose

Iron Polymaltose is reported as an ingredient of Ferimax in the following countries:

• Turkey

International Drug Name Search

Clofarabine

In the US, Clofarabine (clofarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Lymphoblastic Leukemia.

US matches:

• Clofarabine


• Clofarabine Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BB06

CAS registry number (Chemical Abstracts Service)

0123318-82-1

Chemical Formula

C10-H11-Cl-F-N5-O3

Molecular Weight

303

Therapeutic Categories

Immunosuppressant

Dermatological agent: Antipsoriatic

Antineoplastic agent, antimetabolite

Chemical Names

2-Chlor-9-(2-deoxy-2-fluor-beta-D-arabinofuranosyl)adenin

2-Chlor-9-(2-desoxy-2-fluor-beta-D-arabinofuranosyl)purin-6-amin (IUPAC)

2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine (WHO)

9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)- (USAN)

Foreign Names

• Clofarabinum (Latin)
• Clofarabin (German)
• Clofarabine (French)
• Clofarabina (Spanish)

Generic Names

• Clofarabine (OS: USAN, BAN)
• C1-F-Ara-A (IS)
• CAfdA (IS)
• Clofarex (IS)
• Clolar (IS)

Brand Names

• Clolar
  Genzyme, United States



• Evoltra
  Bioenvision, Austria; Bioenvision, Spain; Bioenvision, United Kingdom; Bioenvision, Slovenia; Bioenvision, Slovakia; Bioenvision Limited, Luxembourg; Genzyme, Belgium; Genzyme, Denmark; Genzyme, Finland; Genzyme, France; Genzyme, Greece; Genzyme, Italy; Genzyme, Norway; Genzyme, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Geomycineject

Geomycineject may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Geomycineject

Oxytetracycline

Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Geomycineject in the following countries:

• Netherlands

International Drug Name Search

Vomidon

Vomidon may be available in the countries listed below.

Ingredient matches for Vomidon

Domperidone

Domperidone is reported as an ingredient of Vomidon in the following countries:

• South Africa

International Drug Name Search

Silder

Silder may be available in the countries listed below.

Ingredient matches for Silder

Sulfadiazine

Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Silder in the following countries:

• Turkey

International Drug Name Search

Requin

Requin may be available in the countries listed below.

Ingredient matches for Requin

Quinine

Quinine hydrochloride (a derivative of Quinine) is reported as an ingredient of Requin in the following countries:

• Bangladesh

International Drug Name Search

Eudyna

Eudyna may be available in the countries listed below.

Ingredient matches for Eudyna

Tretinoin

Tretinoin is reported as an ingredient of Eudyna in the following countries:

• Austria


• India


• Indonesia

International Drug Name Search

Eradex

Eradex may be available in the countries listed below.

Ingredient matches for Eradex

Loratadine

Loratadine is reported as an ingredient of Eradex in the following countries:

• Bangladesh

International Drug Name Search

Cefotaxima

Cefotaxima may be available in the countries listed below.

Ingredient matches for Cefotaxima

Cefotaxime

Cefotaxima (DCIT) is known as Cefotaxime in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Laritol

Laritol may be available in the countries listed below.

Ingredient matches for Laritol

Loratadine

Loratadine is reported as an ingredient of Laritol in the following countries:

• Mexico

International Drug Name Search

Fominoben Hydrochloride

Fominoben Hydrochloride may be available in the countries listed below.

Ingredient matches for Fominoben Hydrochloride

Fominoben

Fominoben Hydrochloride (JAN) is also known as Fominoben (Rec.INN)

International Drug Name Search

Glossary

JAN	Japanese Accepted Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Falicard

Falicard may be available in the countries listed below.

Ingredient matches for Falicard

Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Falicard in the following countries:

• Germany


• Romania

International Drug Name Search

Tusilexil

Tusilexil may be available in the countries listed below.

Ingredient matches for Tusilexil

Carbocisteine

Carbocisteine is reported as an ingredient of Tusilexil in the following countries:

• Ecuador

International Drug Name Search

Mimpara

Mimpara may be available in the countries listed below.

UK matches:

• Mimpara
• Mimpara (SPC)

Ingredient matches for Mimpara

Cinacalcet

Cinacalcet is reported as an ingredient of Mimpara in the following countries:

• Germany


• Greece


• Ireland


• Spain


• Switzerland

Cinacalcet hydrochloride (a derivative of Cinacalcet) is reported as an ingredient of Mimpara in the following countries:

• Austria


• Belgium


• Czech Republic


• Denmark


• Finland


• France


• Hungary


• Iceland


• Italy


• Luxembourg


• Netherlands


• Norway


• Poland


• Portugal


• Slovakia


• Slovenia


• Sweden


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Adrenalin Jenapharm

Adrenalin Jenapharm may be available in the countries listed below.

Ingredient matches for Adrenalin Jenapharm

Epinephrine

Epinephrine bitartrate (a derivative of Epinephrine) is reported as an ingredient of Adrenalin Jenapharm in the following countries:

• Germany

International Drug Name Search

Rupek

Rupek may be available in the countries listed below.

Ingredient matches for Rupek

Phytomenadione

Phytomenadione is reported as an ingredient of Rupek in the following countries:

• Argentina

International Drug Name Search

Mono acis

Mono acis may be available in the countries listed below.

Ingredient matches for Mono acis

Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Mono acis in the following countries:

• Germany

International Drug Name Search

Epimil

Epimil may be available in the countries listed below.

Ingredient matches for Epimil

Lamotrigine

Lamotrigine is reported as an ingredient of Epimil in the following countries:

• Bulgaria


• Czech Republic

International Drug Name Search

Doxagen

Doxagen may be available in the countries listed below.

Ingredient matches for Doxagen

Doxazosin

Doxazosin is reported as an ingredient of Doxagen in the following countries:

• Oman


• Poland

International Drug Name Search

Céfaclor RPG

Céfaclor RPG may be available in the countries listed below.

Ingredient matches for Céfaclor RPG

Cefaclor

Cefaclor is reported as an ingredient of Céfaclor RPG in the following countries:

• France

International Drug Name Search

Cetirizn Lek

Cetirizn Lek may be available in the countries listed below.

Ingredient matches for Cetirizn Lek

Cetirizine

Cetirizine is reported as an ingredient of Cetirizn Lek in the following countries:

• Slovenia

International Drug Name Search

Cagudalin

Cagudalin may be available in the countries listed below.

Ingredient matches for Cagudalin

Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Cagudalin in the following countries:

• Japan

International Drug Name Search

Fentanil ratiopharm

Fentanil ratiopharm may be available in the countries listed below.

Ingredient matches for Fentanil ratiopharm

Fentanyl

Fentanyl is reported as an ingredient of Fentanil ratiopharm in the following countries:

• Italy

International Drug Name Search

Cefacetrile

In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DB10

CAS registry number (Chemical Abstracts Service)

0010206-21-0

Chemical Formula

C13-H13-N3-O6-S

Molecular Weight

339

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[(cyanoacetyl)amino]-8-oxo-, (6R-trans)-

Foreign Names

• Cefacetrilum (Latin)
• Cefacetril (German)
• Céfacétrile (French)
• Cefacetrilo (Spanish)

Generic Names

• Cefacetrile (OS: BAN)
• Cefacétrile (OS: DCF)
• 7-Cyanacetylamino-cephalosporansäure (IS)
• Cefacetrile Sodium (OS: BANM)
• Cephacetrile Sodium (OS: USAN)
• Ba 36278 A (IS)
• Cephacetrile Sodium (PH: USP XX)

Brand Name

• Vetimast (veterinary use)
  Novartis Animal Health, United Kingdom

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Loratadina Pharmagenus

Loratadina Pharmagenus may be available in the countries listed below.

Ingredient matches for Loratadina Pharmagenus

Loratadine

Loratadine is reported as an ingredient of Loratadina Pharmagenus in the following countries:

• Spain

International Drug Name Search

Glibenclamide A

Glibenclamide A may be available in the countries listed below.

Ingredient matches for Glibenclamide A

Glibenclamide

Glibenclamide is reported as an ingredient of Glibenclamide A in the following countries:

• Netherlands

International Drug Name Search

Albon

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Albon

Sulfadimethoxine

Sulfadimethoxine is reported as an ingredient of Albon in the following countries:

• United States

International Drug Name Search

Proson

Proson may be available in the countries listed below.

Ingredient matches for Proson

Betamethasone

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Proson in the following countries:

• Indonesia

International Drug Name Search

Salvapen

Salvapen may be available in the countries listed below.

Ingredient matches for Salvapen

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Salvapen in the following countries:

• Spain

International Drug Name Search

Benylin DM

In the US, Benylin DM (dextromethorphan systemic) is a member of the drug class antitussives and is used to treat Cough.

US matches:

• Benylin DM Pediatric

Ingredient matches for Benylin DM

Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Benylin DM in the following countries:

• Canada


• United States

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Benylin DM in the following countries:

• Canada

International Drug Name Search

Risacal-D

Generic Name: calcium and vitamin D combination (KAL see um and VYE ta min D)

Brand Names: Calcarb with D, Calcet, Calcio Del Mar, Calcitrate with D, Calcium 600+D, Caltrate 600 with D, Caltrate 600 with D Plus Soy, Caltrate Colon Health, Citracal + D, Citracal 250 mg + D, Citracal Creamy Bites, Citracal Maximum + D, Citracal Petites, Citrus Calcium with Vitamin D, Dical-D, Os-Cal 250 with D, Os-Cal 500 + D, Os-Cal with D, Oysco 500 with D, Oysco D, Oyst-Cal-D, Oyster Shell Calcium with Vitamin D, Oyster-D, Oystercal-D, Posture-D H/P, Risacal-D

What is Risacal-D (calcium and vitamin D combination)?

Calcium is a mineral that is found naturally in foods. Calcium is necessary for many normal functions of your body, especially bone formation and maintenance.

Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body.

Calcium and vitamin D combination is used to prevent or to treat a calcium deficiency.

Calcium and vitamin D combination may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about Risacal-D (calcium and vitamin D combination)?

Before you take calcium and vitamin D combination, tell your doctor if you have kidney disease, past or present kidney stones, heart disease, circulation problems, a parathyroid disorder, or if you are pregnant or breast-feeding.

Avoid taking any other vitamin or mineral supplements that contain calcium or vitamin D without first talking to your doctor.

Before taking calcium and vitamin D combination, tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

What should I tell my healthcare provider before taking Risacal-D (calcium and vitamin D combination)?

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you take calcium and vitamin D combination, tell your doctor if you have:

• kidney disease;


• past or present kidney stones;


• 
  

  heart disease;

  
  


• 
  

  circulation problems; or

  
  


• 
  

  a parathyroid gland disorder.

  
  

Talk to your doctor before taking calcium and vitamin D combination if you are pregnant. Talk to your doctor before taking calcium and vitamin D combination if you are breast-feeding.

How should I take Risacal-D (calcium and vitamin D combination)?

Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.

Take the calcium and vitamin D regular tablet with a full glass of water.

The chewable tablet should be chewed before you swallow it.

Store calcium and vitamin D combination at room temperature away from moisture and heat.

What happens if I miss a dose?

Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include irregular heartbeat, stomach pain, nausea, vomiting, dry mouth, a metallic taste in your mouth, confusion, loss of appetite, constipation, weakness, headache, confusion, or fainting.

What should I avoid while taking Risacal-D (calcium and vitamin D combination)?

Avoid taking any other vitamin or mineral supplements that contain calcium or vitamin D without first talking to your doctor.

Risacal-D (calcium and vitamin D combination) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects may include:

• 
  

  an irregular heartbeat;

  
  


• 
  

  nausea, vomiting, or decreased appetite;

  
  


• 
  

  dry mouth;

  
  


• 
  

  constipation;

  
  


• 
  

  weakness;

  
  


• 
  

  headache;

  
  


• 
  

  a metallic taste;

  
  


• 
  

  muscle or bone pain; or

  
  


• 
  

  drowsiness.

  
  

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Risacal-D (calcium and vitamin D combination)?

Before taking calcium and vitamin D combination, tell your doctor if you are taking:

• 
  

  digoxin (Lanoxin, Lanoxicaps);

  
  


• 
  

  antacids containing calcium, aluminum, or magnesium;

  
  


• 
  

  other calcium supplements;

  
  


• 
  

  calcitriol (Rocaltrol) or other vitamin D supplements; or

  
  


• 
  

  a tetracycline antibiotic such as demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap).

  
  

This list is not complete and there may be other drugs that can interact with calcium and vitamin D combination. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More Risacal-D resources

• Risacal-D Use in Pregnancy & Breastfeeding
• Risacal-D Drug Interactions
• Risacal-D Support Group
• 0 Reviews for Risacal-D - Add your own review/rating

Compare Risacal-D with other medications

• Dietary Supplementation
• Osteoporosis

Where can I get more information?

• Your pharmacist can provide more information about calcium and vitamin D combination.

Doctinon

Doctinon may be available in the countries listed below.

Ingredient matches for Doctinon

Meloxicam

Meloxicam is reported as an ingredient of Doctinon in the following countries:

• Greece

International Drug Name Search

Voltaren K

Voltaren K may be available in the countries listed below.

Ingredient matches for Voltaren K

Diclofenac

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Voltaren K in the following countries:

• Netherlands

International Drug Name Search

Sulodil

Sulodil may be available in the countries listed below.

Ingredient matches for Sulodil

Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Sulodil in the following countries:

• Greece

International Drug Name Search

Meprobamat

Meprobamat may be available in the countries listed below.

Ingredient matches for Meprobamat

Meprobamate

Meprobamate is reported as an ingredient of Meprobamat in the following countries:

• Romania

International Drug Name Search

Brimonidine/Timolol Drops

Pronunciation: bri-MOE-ni-DEEN/TIM-oh-lol
Generic Name: Brimonidine/Timolol
Brand Name: Combigan

Brimonidine/Timolol Drops are used for:

Treating increased pressure in the eye (ocular hypertension) or open-angle glaucoma. It may also be used for other conditions as determined by your doctor.

Brimonidine/Timolol Drops are an alpha-agonist and beta-blocker combination. It works to decrease fluid production and pressure inside the eye.

Do NOT use Brimonidine/Timolol Drops if:

• you are allergic to any ingredient in Brimonidine/Timolol Drops


• you have severe chronic obstructive pulmonary disease (COPD) or a history of asthma


• you have second or third degree heart block, heart failure, or an unusually slow heartbeat


• you are in shock caused by severe heart problems


• you are using another beta-blocker eye drop (eg, betaxolol)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Brimonidine/Timolol Drops:

Some medical conditions may interact with Brimonidine/Timolol Drops. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of lung or breathing problems (eg, bronchitis, COPD, emphysema), diabetes, low blood sugar, depression, high or low blood pressure (including dizziness on standing), heart problems (eg, heart block, heart failure), certain muscle problems (eg, myasthenia gravis, muscle weakness), blood vessel problems (eg, inflammation), Raynaud phenomenon, or an overactive thyroid


• if you have an eye infection, injury, or other eye problems (eg, narrow-angle glaucoma, double vision)


• if you have decreased blood flow to the heart or brain

Some MEDICINES MAY INTERACT with Brimonidine/Timolol Drops. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Bupivacaine, calcium channel blockers (eg, verapamil), certain antiarrhythmics (eg, disopyramide, flecainide, quinidine), cimetidine, digoxin, furazolidone, ketanserin, monoamine oxidase inhibitors (MAOIs) (eg, phenelzine), reserpine, or selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) because serious heart problems (eg, conduction problems, heart failure, slow heartbeat) or low blood pressure may occur


• Clonidine because high blood pressure may occur


• Tricyclic antidepressants (eg, amitriptyline) because they may decrease Brimonidine/Timolol Drops's effectiveness


• Insulin or oral antidiabetics (eg, glyburide) because the risk of low blood sugar (eg, dizziness, headache, hunger, shakiness or weakness, sweating) may be increased


• Alpha-blockers (eg, alfuzosin, prazosin), oral beta-blockers (eg, propranolol), or other beta-blocker eye drops (eg, betaxolol) because the risk of their side effects may be increased by Brimonidine/Timolol Drops


• Certain sympathomimetics (eg, albuterol, salmeterol), epinephrine, or theophylline because their effectiveness may be decreased by Brimonidine/Timolol Drops

This may not be a complete list of all interactions that may occur. Ask your health care provider if Brimonidine/Timolol Drops may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Brimonidine/Timolol Drops:

Use Brimonidine/Timolol Drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Brimonidine/Timolol Drops are only for the eye. Do not get it in your nose or mouth.


• Soft contact lenses may absorb a chemical in Brimonidine/Timolol Drops. Remove contact lenses before you use Brimonidine/Timolol Drops; lenses may be placed back in the eyes 15 minutes after use of Brimonidine/Timolol Drops.


• To use Brimonidine/Timolol Drops in the eye, first, wash your hands. Tilt your head back. Using your index finger, pull the lower eyelid away from the eye to form a pouch. Drop the medicine into the pouch and gently close your eyes. Immediately use your finger to apply pressure to the inside corner of the eye for 1 to 2 minutes. Do not blink. Remove excess medicine around your eye with a clean, dry tissue, being careful not to touch your eye. Wash your hands to remove any medicine that may be on them.


• To prevent germs from contaminating your medicine, do not touch the applicator tip to any surface, including the eye. Keep the container tightly closed.


• Do NOT overtighten the cap on the bottle. This may damage the bottle or cap.


• Do NOT try to make the hole of the medicine dropper larger.


• Use Brimonidine/Timolol Drops at least 5 minutes before or after any other medicine that you put in your eye.


• Use Brimonidine/Timolol Drops on a regular schedule to get the most benefit from it. Continue to use Brimonidine/Timolol Drops even if you feel well. Do not miss any doses.


• If you miss a dose of Brimonidine/Timolol Drops, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Brimonidine/Timolol Drops.

Important safety information:

• Brimonidine/Timolol Drops may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Brimonidine/Timolol Drops with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Brimonidine/Timolol Drops; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness


• Brimonidine/Timolol Drops may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Tell your doctor or dentist that you use Brimonidine/Timolol Drops before you receive any medical or dental care, emergency care, or surgery.


• Contact your doctor if you have an eye injury or infection, or if you will be having eye surgery.


• Diabetes patients - Brimonidine/Timolol Drops may hide signs of low blood sugar, such as a rapid heartbeat. Be sure to watch for other signs of low blood sugar. Low blood sugar may make you anxious, sweaty, weak, dizzy, drowsy, or faint. It may also make your vision change; give you a headache, chills, or tremors; or make you more hungry. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• If you have a history of any severe allergic reaction, talk with your doctor. You may be at risk for an even more severe allergic reaction if you come into contact with the substance that caused your allergy. Some medicines used to treat severe allergies may also not work as well while you are using Brimonidine/Timolol Drops.


• Brimonidine/Timolol Drops may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.


• Lab tests, including eye pressure, may be performed while you use Brimonidine/Timolol Drops. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Caution is advised when using Brimonidine/Timolol Drops in CHILDREN; they may be more sensitive to its effects, especially drowsiness


• Brimonidine/Timolol Drops should not be used in CHILDREN younger than 2 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Brimonidine/Timolol Drops while you are pregnant. Brimonidine/Timolol Drops are found in breast milk. Do not breast-feed while taking Brimonidine/Timolol Drops.

Possible side effects of Brimonidine/Timolol Drops:

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Bloodshot eyes; drowsiness; dry eyes; feeling that something is in your eye; headache; increased tear production; minor burning, itching, or stinging of the eye; nausea.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain or discomfort; confusion; eye irritation, swelling, pain, or discharge; eyelid pain, redness, scaling, drooping, or swelling; fainting; mental or mood changes; muscle weakness; pain, numbness, weakness, or tingling of an arm or leg; severe or persistent headache or dizziness; severely cold, numb, or blue fingers or toes; shortness of breath; slow or irregular heartbeat; slurred speech; sudden unusual weight gain; swelling of the hands, ankles, or feet; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Brimonidine/Timolol side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include chest pain; difficulty breathing or shortness of breath; dizziness; severe or persistent headache; slow or irregular heartbeat.

Proper storage of Brimonidine/Timolol Drops:

Store Brimonidine/Timolol Drops at room temperature, between 59 and 77 degrees F (15 and 25 degrees C). Store away from heat, moisture, and light. Keep Brimonidine/Timolol Drops out of the reach of children and away from pets.

General information:

• If you have any questions about Brimonidine/Timolol Drops, please talk with your doctor, pharmacist, or other health care provider.


• Brimonidine/Timolol Drops are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Brimonidine/Timolol Drops. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Brimonidine/Timolol resources

• Brimonidine/Timolol Side Effects (in more detail)
• Brimonidine/Timolol Use in Pregnancy & Breastfeeding
• Brimonidine/Timolol Drug Interactions
• Brimonidine/Timolol Support Group
• 2 Reviews for Brimonidine/Timolol - Add your own review/rating

Compare Brimonidine/Timolol with other medications

• Glaucoma
• Glaucoma/Intraocular Hypertension
• Intraocular Hypertension

Kristapen

Kristapen may be available in the countries listed below.

Ingredient matches for Kristapen

Benzylpenicillin

Benzylpenicillin potassium (a derivative of Benzylpenicillin) is reported as an ingredient of Kristapen in the following countries:

• Turkey

International Drug Name Search

Emitex

Emitex may be available in the countries listed below.

Ingredient matches for Emitex

Fenoterol

Fenoterol hydrobromide (a derivative of Fenoterol) is reported as an ingredient of Emitex in the following countries:

• Japan

International Drug Name Search

Amipor

Amipor may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amipor

Amitraz

Amitraz is reported as an ingredient of Amipor in the following countries:

• South Africa

Cypermethrin

Cypermethrin is reported as an ingredient of Amipor in the following countries:

• South Africa

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Amipor in the following countries:

• South Africa

International Drug Name Search

Uterone

Uterone may be available in the countries listed below.

Ingredient matches for Uterone

Tibolone

Tibolone is reported as an ingredient of Uterone in the following countries:

• India

International Drug Name Search

Froxime

Froxime may be available in the countries listed below.

Ingredient matches for Froxime

Cefuroxime

Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Froxime in the following countries:

• Bahrain


• Iraq


• Jordan


• Kuwait


• Lebanon


• Libya


• Nigeria


• Qatar


• Saudi Arabia


• Somalia


• Sudan


• United Arab Emirates


• Yemen

International Drug Name Search

Lupocet

Lupocet may be available in the countries listed below.

Ingredient matches for Lupocet

Paracetamol

Paracetamol is reported as an ingredient of Lupocet in the following countries:

• Bosnia & Herzegowina


• Croatia (Hrvatska)

International Drug Name Search

Temic

Temic may be available in the countries listed below.

Ingredient matches for Temic

Cimetidine

Cimetidine is reported as an ingredient of Temic in the following countries:

• Italy

International Drug Name Search

Fosfocreatinine

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0005786-71-0

Chemical Formula

C4-H8-N3-O4-P

Molecular Weight

193

Therapeutic Category

Cardiac agent

Chemical Name

Phosphoramidic acid, (4,5-dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)-

Foreign Names

• Fosfocreatininum (Latin)
• Fosfocreatinin (German)
• Fosfocréatinine (French)
• Fosfocreatinina (Spanish)

Generic Name

• Fosfocreatinina (OS: DCIT)

Brand Names

• Sustenium Energy
  Menarini, Costa Rica; Menarini, Dominican Republic; Menarini, Guatemala; Menarini, Honduras; Menarini, Nicaragua; Menarini, Panama; Menarini, El Salvador

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Azimycin

Azimycin may be available in the countries listed below.

Ingredient matches for Azimycin

Azithromycin

Azithromycin is reported as an ingredient of Azimycin in the following countries:

• Poland

International Drug Name Search

Triamtereen CF

Triamtereen CF may be available in the countries listed below.

Ingredient matches for Triamtereen CF

Triamterene

Triamterene is reported as an ingredient of Triamtereen CF in the following countries:

• Netherlands

International Drug Name Search

Crystapen

Crystapen may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

UK matches:

• Crystapen Injection (SPC)

Ingredient matches for Crystapen

Benzylpenicillin

Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Crystapen in the following countries:

• Canada


• Ireland


• United Kingdom

Phenoxymethylpenicillin

Phenoxymethylpenicillin is reported as an ingredient of Crystapen in the following countries:

• Bangladesh

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Cefotaxima Combino Pharm

Cefotaxima Combino Pharm may be available in the countries listed below.

Ingredient matches for Cefotaxima Combino Pharm

Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Cefotaxima Combino Pharm in the following countries:

• Spain

International Drug Name Search

Omeprazol AWD

Omeprazol AWD may be available in the countries listed below.

Ingredient matches for Omeprazol AWD

Omeprazole

Omeprazole is reported as an ingredient of Omeprazol AWD in the following countries:

• Germany

International Drug Name Search

Etamsylate

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B02BX01

CAS registry number (Chemical Abstracts Service)

0002624-44-4

Chemical Formula

C10-H17-N-O5-S

Molecular Weight

263

Therapeutic Category

Hemostatic agent

Chemical Name

Benzenesulfonic acid, 2,5-dihydroxy-, compd. with N-ethylethanamine (1:1)

Foreign Names

• Etamsylatum (Latin)
• Etamsylat (German)
• Etamsylate (French)
• Etamsilato (Spanish)

Generic Names

• Etamsilato (OS: DCIT)
• Etamsylate (OS: BAN, JAN)
• Étamsylate (OS: DCF)
• Ethamsylate (OS: BAN, USAN)
• Ciclonamina (IS)
• E 141 (IS)
• Etamsylat (PH: Ph. Eur. 6)
• Etamsylate (PH: BP 2010, Ph. Eur. 6)
• Etamsylatum (PH: Ph. Eur. 6)

Brand Names

• Alstat
  Albert David, India



• Cyclonamine
  Galena, Poland; Polpharma, Poland; Polpharma, Vietnam



• Dicinone
  Pensa, Spain



• Dicynene
  Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Ireland



• Dicynone
  B & O Pharm, France; Corsa Industries, Indonesia; Grünenthal, Mexico; Lek, Bosnia & Herzegowina; Lek, Georgia; Lek, Croatia (Hrvatska); Lek, Lithuania; Lek, Latvia; Lek, Serbia; Lek, Russian Federation; Leti, Venezuela; OM, Bulgaria; OM, Bahrain; OM, Czech Republic; OM, Malta; OM, Peru; OM, Romania; OM, Slovakia; OM Pharma, Switzerland; OM Pharma, Indonesia; OM Pharma, Oman; OM Pharma, Singapore; Sanofi Aventis, Tunisia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Italy; Sanofi-Synthelabo, Luxembourg; Teva, Hungary; Wyeth, Colombia



• Eselin
  Sifarma, Italy



• Etamsilat
  Sicomed, Romania



• Etamsylatum
  Olainfarm, Latvia



• Etamzilats
  Kalceks, Latvia



• Ethasyl
  FDC, India



• Hemo 141
  Laboratorios Dr Esteve, Spain



• Hémoced (veterinary use)
  Intervet, France



• Hemsyl
  Indoco, India



• Impedil
  Phoenix, Argentina



• Lizhining
  Changzheng, China



• OM-Dicynone
  Labomed, Chile



• Quercetol
  California, Colombia



• Stadmed Ethacid
  Stadmed, India



• Wincynon
  Winston, Taiwan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Travelgum

Travelgum may be available in the countries listed below.

Ingredient matches for Travelgum

Dimenhydrinate

Dimenhydrinate is reported as an ingredient of Travelgum in the following countries:

• Austria


• Italy

International Drug Name Search

Moxonidin Hexal

Moxonidin Hexal may be available in the countries listed below.

Ingredient matches for Moxonidin Hexal

Moxonidine

Moxonidine is reported as an ingredient of Moxonidin Hexal in the following countries:

• Estonia


• Germany


• Latvia


• Lithuania

International Drug Name Search

Cétirizine Ratiopharm Conseil

Cétirizine Ratiopharm Conseil may be available in the countries listed below.

Ingredient matches for Cétirizine Ratiopharm Conseil

Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cétirizine Ratiopharm Conseil in the following countries:

• France

International Drug Name Search

Rhinocort Turbuhaler

Rhinocort Turbuhaler may be available in the countries listed below.

Ingredient matches for Rhinocort Turbuhaler

Budesonide

Budesonide is reported as an ingredient of Rhinocort Turbuhaler in the following countries:

• Iceland


• Ireland


• Norway


• Sweden


• Switzerland

International Drug Name Search

Beyaz

Beyaz is a brand name of drospirenone/ethinyl estradiol/levomefolate calcium, approved by the FDA in the following formulation(s):

BEYAZ (drospirenone; ethinyl estradiol; levomefolate calcium - tablet; oral)

• 
  Manufacturer: BAYER HLTHCARE
  
  Approval date: September 24, 2010
  
  Strength(s): 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG ^[RLD]

Has a generic version of Beyaz been approved?

No. There is currently no therapeutically equivalent version of Beyaz available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Beyaz. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Solid dosage forms that contain clathrates of 17.alpha.-ethinyl estradiol
  Patent 5,798,338
  Issued: August 25, 1998
  Inventor(s): Backensfeld; Thomas & Tack; Johannes
  Assignee(s): Schering Aktiengesellschaft
  A method and pharmaceutical compositions are disclosed for reducing oxidative degradation of 17 .alpha.-ethinylestradiol comprising combining the estradiol with an effective amount of cyclodextrin, thus forming a cyclodextrin clathrate of the steroid.
  
  Patent expiration dates:
  
  
  • July 10, 2015
    
    ✓ 
    Drug product
  
  



• 
  Stable crystalline salts of 5-methyltetrahydrofolic acid
  Patent 6,441,168
  Issued: August 27, 2002
  Inventor(s): Rudolf; Müller & Rudolf; Moser & Thomas; Egger
  Assignee(s): Eprova AG
  This invention relates to stable crystalline salts of 5-methyl-(6R,S)-, -(6S)- and -(6R)-tetrahydrofolic acid, to methods of producing these salts and to the use thereof use as a constituent for the production of drugs or as a food additive, and to preparations containing these salts.
  
  Patent expiration dates:
  
  
  • April 17, 2020
    
    ✓ 
    Drug substance
  
  



• 
  Cyclodextrin-drospirenone inclusion complexes
  Patent 6,958,326
  Issued: October 25, 2005
  Inventor(s): Backensfeld; Thomas & Heil; Wolfgang & Lipp; Ralph
  Assignee(s): Schering AG
  Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition comprises a complex between ethinyl estradiol and β-cyclodextrin in a granulate preparation and in yet another embodiment the composition comprises a limited amount of polyvinylpyrrolidone since this excipient was found to degrade ethinyl estradiol. Furthermore, a method for improving the stability of an estrogen in a composition and for manufacturing such a stable composition is provided. Essentially, the granulate preparation are manufactured under careful control of the relative humidity.
  
  Patent expiration dates:
  
  
  • December 30, 2021
    
    ✓ 
    Drug product
  
  



• 
  Compositions of estrogen-cyclodextrin complexes
  Patent 7,163,931
  Issued: January 16, 2007
  Inventor(s): Backensfeld; Thomas & Heil; Wolfgang & Lipp; Ralph
  Assignee(s): Schering Aktiengesellchaft
  Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition comprises a complex between ethinyl estradiol and β-cyclodextrin in a granulate preparation and in yet another embodiment the composition comprises a limited amount of polyvinylpyrrolidone since this excipient was found to degrade ethinyl estradiol. Furthermore, a method for improving the stability of an estrogen in a composition and for manufacturing such a stable composition is provided. Essentially, the granulate preparation are manufactured under careful control of the relative humidity.
  
  Patent expiration dates:
  
  
  • March 3, 2022
    
    ✓ 
    Patent use: PREVENTION OF PREGNANCY
  
  



• 
  Composition for contraception
  Patent RE37564
  Issued: February 26, 2002
  Inventor(s): Jürgen; Spona & Bernd; Düsterberg & Frank; Lüdicke
  Assignee(s): Schering Aktiengesellschaft
  A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17&bgr;-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from 0.25 to 0.30 2.5 to 3.0 mg of drospirenone and 0.1 to 0.2 1 to 2 mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.
  
  Patent expiration dates:
  
  
  • June 30, 2014
    
    ✓ 
    Drug product
  
  



• 
  Composition for contraception
  Patent RE37838
  Issued: September 10, 2002
  Inventor(s): Jürgen; Spona & Bernd; Düsterberg & Frank; Lüdicke
  Assignee(s): Schering Aktiengesellschaft
  A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17&bgr;-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from 0.25 to 0.30 mg of drospirenone and 0.1 to 0.2 mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.
  
  Patent expiration dates:
  
  
  • June 30, 2014
    
    ✓ 
    Drug product
  
  



• 
  Composition for contraception
  Patent RE38253
  Issued: September 16, 2003
  Inventor(s): Jürgen; Spona & Bernd; Düsterberg & Frank; Lüdicke
  Assignee(s): Schering Aktiengesellschaft
  A combination product for oral contraception is disclosed comprising an estrogen selected from 2.0 to 6.0 mg of 17&bgr;-estradiol and 0.020 mg of ethinylestradiol; and a gestagen selected from 0.25 to 0.30 2.5 to 3.0 mg of drospirenone and 0.1 to 0.2 1 to 2 mg of cyproterone acetate, followed by 5 or 4 pill-free or sugar pill days.
  
  Patent expiration dates:
  
  
  • June 30, 2014
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • September 24, 2013 - NEW COMBINATION
  
  
  • September 24, 2013 - NEW PRODUCT
  
  

See also...

• Beyaz Consumer Information (Drugs.com)
• Beyaz Consumer Information (Wolters Kluwer)
• Beyaz Consumer Information (Cerner Multum)
• Beyaz Advanced Consumer Information (Micromedex)
• Drospirenone/Ethinyl Estradiol/Levomefolate Consumer Information (Wolters Kluwer)
• Drospirenone, ethinyl estradiol, and levomefolate Consumer Information (Cerner Multum)
• Drospirenone, ethinyl estradiol, and levomefolate Advanced Consumer Information (Micromedex)